Literature DB >> 25181969

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 1 Introduction/preliminary comments].

U Kiltz1, J Sieper, M Rudwaleit, H Kellner, D Krause, E Böhle, H Böhm, W-H Böhncke, J-F Chenot, A Heiligenhaus, K-G Hermann, S Jaresch, W Mau, U Oberschelp, U Pleyer, U Repschläger, E Schneider, U Smolenski, A Stallmach, M Stemmer, B Swoboda, C Ulrich, M Winking, J Braun.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25181969     DOI： 10.1007/s00393-014-1426-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  13 in total

1.  Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

Authors:  Wilfried Mau; Joachim Listing; Doerte Huscher; Henning Zeidler; Angela Zink
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

2.  Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.

Authors:  Annelies Boonen; Tjinta Brinkhuizen; Robert Landewé; Désirée van der Heijde; Johan L Severens
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

3.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

4.  Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

Authors:  J Braun; M Bollow; G Remlinger; U Eggens; M Rudwaleit; A Distler; J Sieper
Journal:  Arthritis Rheum       Date:  1998-01

5.  Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions.

Authors:  Hanne Dagfinrud; Ingvild Kjeken; Petter Mowinckel; Kaare B Hagen; Tore K Kvien
Journal:  J Rheumatol       Date:  2005-03       Impact factor: 4.666

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.

Authors:  M Rudwaleit; R Landewé; D van der Heijde; J Listing; J Brandt; J Braun; R Burgos-Vargas; E Collantes-Estevez; J Davis; B Dijkmans; M Dougados; P Emery; I E van der Horst-Bruinsma; R Inman; M A Khan; M Leirisalo-Repo; S van der Linden; W P Maksymowych; H Mielants; I Olivieri; R Sturrock; K de Vlam; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

7.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

8.  Impact of ankylosing spondylitis on work and family life: comparisons with the US population.

Authors:  Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2008-04-15

9.  Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.

Authors:  R Landewé; M Dougados; H Mielants; H van der Tempel; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2008-07-15       Impact factor: 19.103

Review 10.  Ankylosing spondylitis.

Authors:  Jürgen Braun; Joachim Sieper
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321
View more
  2 in total

Review 1.  [Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

2.  [Cornerstones of quality assurance in medicine in Germany. Important impulse for the situation in treatment of rheumatism].

Authors:  J Braun; M Schneider; H-J Lakomek
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.